EX-23.1 2 ex_475247.htm EXHIBIT 23.1 ex_475247.htm

Exhibit 23.1

 

 

Consent of Independent Registered Public Accounting Firm

 

We consent to the reference to our firm under the caption "Experts" in the Registration Statement (Form S-1) and related Prospectus of Windtree Therapeutics, Inc. and to the incorporation by reference therein of our report dated March 31, 2022, with respect to the consolidated financial statements of Windtree Therapeutics, Inc. included in its Annual Report (Form 10-K) for the year ended December 31, 2021, filed with the Securities and Exchange Commission.

 

 

 

/s/ Ernst & Young LLP

 

 

Philadelphia, Pennsylvania

 

February 14, 2023